KATIE WALSH: Open Payments
NPI 1053939215 · POWELL, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$458 in 22 payments from 9 companies in 2025. Trend: 2023 $360 · 2024 $624 · 2025 $458
Food & beverage: $458
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $144 |
| Novo Nordisk Inc | 4 | $96 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $63 |
| Xeris Pharmaceuticals, Inc. | 2 | $35 |
| Phathom Pharmaceuticals, Inc. | 2 | $35 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Dynavax Technologies Corporation | 1 | $23 |
| Lilly USA, LLC | 1 | $16 |
| Astellas Pharma US Inc | 1 | $14 |
Products named: VRAYLAR, Ozempic, XIFAXAN, GVOKE HYPOPEN, VOQUEZNA, Heplisav-B, Wegovy, TRELEGY ELLIPTA.
Industry payments across TN — which companies pay providers there.
